SAB Biotherapeutics (SABS) Other Non-Current Liabilities (2021 - 2026)
SAB Biotherapeutics (SABS) posted Other Non-Current Liabilities of $7.23 million for Q2 2026, up 265.0% from $1.98 million a year earlier and up 18.2% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Other Non-Current Liabilities came in at $5.64 million, down 11.8% from FY2024.
- Annual Other Non-Current Liabilities shows a four-year compound annual growth rate of -14.9% (FY2021 to FY2025).
- In prior years, SAB Biotherapeutics' Other Non-Current Liabilities was $6.39 million in FY2024 (-45.7%), $11.77 million in FY2023, $320,930 in FY2022 (-97.0%) and $10.72 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Other Non-Current Liabilities since Q4 2023.
- On a year-over-year basis, Other Non-Current Liabilities increased in three of the last eight quarters, with growth averaging 158.3%.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q3 2024, with growth of 878.9%; the weakest was Q4 2022, with a decline of 97.0%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $6.12 million (Q1 2026), $5.64 million (Q4 2025) and $2.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.58 Mn |
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 5.64 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 6.39 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 6.31 Mn |
| Dec 31, 2023 | 11.77 Mn |
| Sep 30, 2023 | 417,102.00 |
| Jun 30, 2023 | 595,860.00 |
| Mar 31, 2023 | 238,344.00 |
| Dec 31, 2022 | 320,930.00 |
| Sep 30, 2022 | 357,516.00 |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 2.87 Mn |
| Dec 31, 2021 | 10.72 Mn |
API Access
SAB Biotherapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();